TUESDAY, July 12, 2022 (HealthDay News) The COVID pandemic has eaten into the progress made against drug-resistant infections, according to the U.S. Centers for Disease Control and Prevention.
The COVID-19 pandemic significantly degraded the strides made over the last two decades in improving patient safety, particularly in long-term care, according to CMS and the CDC. In response, APIC has launched a new campaign to reduce HAIs.
The Centers for Disease Control and Prevention (CDC) announced today that it has awarded $22 million to nearly 30 organizations around the world to combat antimicrobial resistance (AR) and other healthcare threats through the establishment of two new networks-;the Global Action in Healthcare Network (GAIHN) and the Global AR Laboratory and Response Network (Global AR Lab & Response Network).